CVS beats on profit as prescription sales surge

Net income attributable to the company rose to $998 million, or $0.98 per share, in the first quarter ended March 31 from $952 million, or $0.92 per share, a year earlier."CVS beats on profit as prescription sales surge" via FOX BIZ https://ift.tt/2w8p1T0